Search Results - ACUTE MYELOID LEUKAEMIA

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    New Therapeutic Approaches for Acute Myeloid Leukaemia by Ruth M Risueno, Laia Cuesta-Casanovas, Jose M Carbo, Josep M Cornet-Masana

    Published in European Medical Journal (2021-06-01)
    “… Acute myeloid leukaemia (AML) is a genetically heterogeneous haematopoietic neoplasm characterised by the accumulation of transformed immature blood progenitors in bone marrow. …”
    Get full text
    Article
  5. 5
  6. 6

    Spatial distribution of acute myeloid leukaemia in Denmark by Rikke Hedegaard Jensen, Christian Teglgaard, Lars Hernández Nielsen, Lise Dueholm Bertelsen, Heidi Søgaard Christensen, Martin Bøgsted, Marianne Tang Severinsen

    Published in Environmental Health (2025-04-01)
    “…Abstract Background Although various occupational and environmental exposures are suspected risk factors for acute myeloid leukaemia (AML), the aetiology of AML is largely unknown. …”
    Get full text
    Article
  7. 7
  8. 8
  9. 9

    Granulocytic Sarcoma in an Adult with Relapsed Acute Myeloid Leukaemia by Neethu Ann Kurien, Deepa John, Geeta Chacko, Pushpa Jacob

    “…Granulocytic sarcoma is an extramedullary tumour consisting of malignant granulocytic precursor cells that is common among children with acute myeloid leukaemia (AML). We report a case of orbital granulocytic sarcoma in an adult with relapsed undifferentiated AML–M0. …”
    Get full text
    Article
  10. 10
  11. 11

    Transcriptional Regulation by the NFAT Family in Acute Myeloid Leukaemia by Shaun D. Patterson, Xu Huang, Heather G. Jørgensen, Alison M. Michie

    Published in Hemato (2021-08-01)
    “…Acute myeloid leukaemia (AML) is a haematological cancer with poor outcomes due to a lack of efficacious targeted therapies. …”
    Get full text
    Article
  12. 12

    Hypocellular Acute Myeloid Leukaemia-A Diagnostic Conundrum by Sindhura Lakshmi Koulmane Laxminarayana, Chethan Manohar

    “…In this report, we describe an unusual case of Hypocellular Acute Myeloid Leukaemia (H-AML) without any past haematologic disease or radio/chemotherapy in an elderly male. …”
    Get full text
    Article
  13. 13
  14. 14
  15. 15

    Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia. by Felix Jost, Enrico Schalk, Kristine Rinke, Thomas Fischer, Sebastian Sager

    Published in PLoS ONE (2019-01-01)
    “…We investigate the personalisation and prediction accuracy of mathematical models for white blood cell (WBC) count dynamics during consolidation treatment using intermediate or high-dose cytarabine (Ara-C) in acute myeloid leukaemia (AML). Ara-C is the clinically most relevant cytotoxic agent for AML treatment. …”
    Get full text
    Article
  16. 16

    Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia by Sean Harrop, Phillip C. Nguyen, David Byrne, Clarissa Wilson, Georgina L. Ryland, Tamia Nguyen, Mary Ann Anderson, Seong Lin Khaw, Michelle Martin, Ing Soo Tiong, Elaine Sanij, Piers Blombery

    Published in eJHaem (2023-11-01)
    “…Abstract UBTF tandem duplications are recurrent in adult and paediatric acute myeloid leukaemia and have been reported to be associated with a poor prognosis. …”
    Get full text
    Article
  17. 17

    Olutasidenib: A ray of hope in the treatment of acute myeloid leukaemia by Bhupender Nehra, Manoj Kumar, Sumitra Singh, Pooja A. Chawla

    Published in Health Sciences Review (2023-06-01)
    “…Acute myeloid leukaemia (AML) or Myelodysplastic syndrome (MDS) is one of the most common and life-threatening forms of blood cancer spreading worldwide. …”
    Get full text
    Article
  18. 18
  19. 19
  20. 20

Search Tools: